Self Medication with Methoxetamine as an Analgesic Resulting in Significant Toxicity.
K. Maskell, Michael D. Bailey, S. R. Rose
Pain Medicine September 1, 2016 DOI: 10.1093/pm/pnw041 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | 29-year-old man with chronic foot pain |
| Intervention | Methoxetamine |
| Key findings | Self-medication with methoxetamine for chronic foot pain led to severe toxicity including altered mental status, agitation, and dissociative symptoms. |
Abstract
Dear Editor, Methoxetamine (MXE) is a non-scheduled arylcyclohexylamine drug of abuse with clinical effects similar to ketamine or phencyclidine [1]. We report a case of MXE toxicity after self-medicating for treatment of chronic foot pain. A 29-year-old man was brought to the emergency department (ED) for altered mental status. He was apprehended by police after running into the street and lying down in front of oncoming traffic, including a police car. He was agitated and combative for emergency medical services (EMS), eventually requiring restraints. EMS also noted white foam around his mouth. A plastic bag containing white powder, labeled MXE with CAS number 1239943-76-0, was found in his pocket (see Figure 1). On presentation to the ED, vital signs included a heart rate of 117, blood pressure 140/81, respiratory rate 28, and temperature of 37.1 degrees celsius orally. Neurologic signs included dysphoria, psychomotor agitation, vertical nystagmus, labile mood, and dissociative confusion, including partial amnesia to the preceding events. The patient was given 10mg IV diazepam in the ED which resulted in a calmer, more euphoric state though his mood remained labile. He answered some questions appropriately but …
Citations in the library
Cited by 6
- Combined NMDA Inhibitor Use in a Patient With Multisubstance-induced Psychotic Disorder Journal of Addiction Medicine February 4, 2018
- New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT2 receptors in pharmacological and behavioral effects in the rat. Experimental Neurology November 1, 2021
- Self-medication with Novel Psychoactive Substances (NPS): a Systematic Review International Journal of Mental Health and Addiction November 28, 2023
- Methoxetamine: A foe or friend? Neurochemistry International 2019
- 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances. Handbook of experimental pharmacology 2018
and 1 more in the library
Cites 7
- The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. PLoS One June 14, 2016
- From “Special K” to “Special M”: The Evolution of the Recreational Use of Ketamine and Methoxetamine CNS Neuroscience & Therapeutics June 1, 2013
- Methoxetamine (MXE) – A Phenomenological Study of Experiences Induced by a “Legal High” from the Internet Journal of Psychoactive Drugs July 1, 2013
- The ketamine analog methoxetamine: a new designer drug to threaten military readiness. Military Medicine September 29, 2014
- Methoxetamine--a novel recreational drug with potent hallucinogenic properties. Toxicology Letters November 4, 2014
and 2 more in the library